Protagonist Therapeutics Announces U.S. FDA Approval of ICOTYDE(TM) (icotrokinra) for the Treatment of Moderate to Severe Plaque Psoriasis

ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill Approval supported by four phase 3 studies that met ...
Business Recorder

Buying returns to bourse, KSE-100 up nearly 2,200 points in early trade

On Monday, the PSX witnessed a sharp sell-off as the benchmark KSE-100 Index plunged, as investors remained wary due to ...

Ease Prices Or Obey IMF? Why Iran War Oil Shock Has Left Pakistan In A Bind

Pakistan is navigating a dilemma between fulfilling strict fiscal requirements of its $7-billion IMF programme and protecting citizens from record-breaking inflation during Ramadan ...
The Express Tribune

Govt approves weekly oil price proposals

ISLAMABAD: The government has approved a set of proposals for oil price review on a weekly basis aimed at bailing out the oil ...
Business Recorder

Volatility at bourse, KSE-100 closes above 150,000 level

A volatile trading session was observed at the Pakistan Stock Exchange (PSX) with the benchmark KSE-100 Index swinging both ...